Drugs / Sodium hexafluoride
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03333330 Background | Apr 2012 → Oct 2017 | atherosclerosis, ischemic stroke | Enrico Ammirati | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium hexafluoride | “Sodium hexafluoride (SonoVue, Bracco Imaging, Milan, Italy) for CEUS” NCT03333330 ↗ |
| Known as | SonoVue | “Sodium hexafluoride (SonoVue, Bracco Imaging, Milan, Italy) for CEUS” NCT03333330 ↗ |
| Modality | Diagnostic / imaging agent | “for CEUS” NCT03333330 ↗ |